Skip to search formSkip to main contentSkip to account menu

Endothelial Growth Factor Receptor

Known as: Receptor, Endothelial Growth Factors 
National Institutes of Health

Related topics

Related topics

2 relations

Narrower (2)

Vascular Endothelial Growth Factor ReceptorVascular Endothelial Growth Factor Receptor-1

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
A Flare for the Unexpected: Bone Flare as Response to Tyrosine Kinase Inhibitor Treatment in a Lung Cancer Patient
We report the case of a 72-year-old female never-smoker with stage IV endothelial growth factor receptor (EGFR) mutated lung… 
Review
2016
Review
2016
Afatinib-Induced Acute Fatal Pneumonitis in Metastatic Lung Adenocarcinoma
Afatinib is an oral tyrosine kinase inhibitor (TKI) that inhibit Endothelial Growth Factor Receptor (EGFR), Human Epidermal… 
Review
2016
Review
2016
Genetic alterations in lung adenocarcinoma with a micropapillary component.
Pulmonary adenocarcinoma (PA) with a micropapillary component (PA-MPC) is known as an aggressive subtype of PA. The molecular… 
Review
2013
Review
2013
Incidence and risk of hypomagnesemia in advanced cancer patients treated with cetuximab: A meta-analysis
Hypomagnesemia is a serious adverse event for patients treated with cetuximab, an inhibitor of endothelial growth factor receptor… 
2013
2013
Rapid characterization of a novel taspine derivative-HMQ1611 binding to EGFR by a cell membrane chromatography method.
A new high-expression endothelial growth factor receptor (EGFR) cell membrane chromatography (CMC) method was applied to… 
2012
2012
Diffuse interstitial lung disease linked to vandetanib.
2011
2011
Regulation of colon cancer cell proliferation and migration by MD-2 activity
Evidence suggests that signalling through lipopolysaccharide (LPS) has a significant role in the development of gastrointestinal… 
Review
2011
Review
2011
The efficacy of gemcitabine as salvage treatment in patients with refractory advanced colorectal cancer (CRC): a single institution experience.
OBJECTIVE To assess the efficacy of gemcitabine based chemotherapy in heavily pre-treated patients with advanced colorectal… 
2011
2011
BRAF p.Val600Glu (V600E) somatic mutation is mainly associated with MSS phenotype in metastatic colorectal cancer.
BACKGROUND Oncogenic activation of EGF-signalling pathway is central to the progression of colorectal cancer. The use of… 
2010
2010
Relation of the Expression of Cyclooxygenase-2 in Colorectal Adenomas and Adenocarcinomas to Angiogenesis and Prognosis
Purpose Recent studies have shown that cyclooxygenase (COX)-2 may be involved in tumor growth, invasion and apoptosis in various… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)